These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29912760)

  • 1. The Role of Insulin-like Growth Factor (IGF) Axis in Early Diagnosis of Pancreatic Adenocarcinoma (PDAC).
    Wlodarczyk B; Gasiorowska A; Malecka-Panas E
    J Clin Gastroenterol; 2018 Aug; 52(7):569-572. PubMed ID: 29912760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon/insulin ratio as a potential biomarker for pancreatic cancer in patients with new-onset diabetes mellitus.
    Kolb A; Rieder S; Born D; Giese NA; Giese T; Rudofsky G; Werner J; Büchler MW; Friess H; Esposito I; Kleeff J
    Cancer Biol Ther; 2009 Aug; 8(16):1527-33. PubMed ID: 19571666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse Oncologic Impact of New-Onset Diabetes Mellitus on Recurrence in Resected Pancreatic Ductal Adenocarcinoma: A Comparison With Long-standing and Non-Diabetes Mellitus Patients.
    Lee S; Hwang HK; Kang CM; Lee WJ
    Pancreas; 2018 Aug; 47(7):816-822. PubMed ID: 29975349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes associated with pancreatic ductal adenocarcinoma is just diabetes: Results of a prospective observational study in surgical patients.
    Dugnani E; Gandolfi A; Balzano G; Scavini M; Pasquale V; Aleotti F; Liberati D; Di Terlizzi G; Petrella G; Reni M; Doglioni C; Bosi E; Falconi M; Piemonti L
    Pancreatology; 2016; 16(5):844-52. PubMed ID: 27546476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 Diabetes Mellitus and Its Association with the Risk of Pancreatic Carcinogenesis: A Review.
    Biadgo B; Abebe M
    Korean J Gastroenterol; 2016 Apr; 67(4):168-77. PubMed ID: 27112242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adaptor protein CrkII regulates IGF-1-induced biological behaviors of pancreatic ductal adenocarcinoma.
    Liu R; Wang Q; Xu G; Li K; Zhou L; Xu B
    Tumour Biol; 2016 Jan; 37(1):817-22. PubMed ID: 26250463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
    Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC
    Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical profiles and long-term outcomes of patients with pancreatic ductal adenocarcinoma and diabetes mellitus.
    Ben Q; Xu M; Jiang Y; Yuan Y; Wang K; Fang J; Li Z
    Diabetes Metab Res Rev; 2012 Feb; 28(2):169-76. PubMed ID: 22423386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Implications of NRAS Overexpression in Resectable Pancreatic Adenocarcinoma Patients.
    Martinez-Useros J; Li W; Georgiev-Hristov T; Fernandez-Aceñero MJ; Borrero-Palacios A; Perez N; Celdran A; Garcia-Foncillas J
    Pathol Oncol Res; 2019 Jan; 25(1):269-278. PubMed ID: 29101736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer.
    Polvani S; Tarocchi M; Tempesti S; Bencini L; Galli A
    World J Gastroenterol; 2016 Feb; 22(8):2441-59. PubMed ID: 26937133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-891b is an independent prognostic factor of pancreatic cancer by targeting Cbl-b to suppress the growth of pancreatic cancer cells.
    Dong Q; Li C; Che X; Qu J; Fan Y; Li X; Li Y; Wang Q; Liu Y; Yang X; Qu X
    Oncotarget; 2016 Dec; 7(50):82338-82353. PubMed ID: 27494897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rationale and development of therapeutic insulin-like growth factor axis inhibition for lung and other cancers.
    Camidge DR; Dziadziuszko R; Hirsch FR
    Clin Lung Cancer; 2009 Jul; 10(4):262-72. PubMed ID: 19632946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor 1 and insulin-like growth factor binding protein 2 serum levels as potential biomarkers in differential diagnosis between chronic pancreatitis and pancreatic adenocarcinoma in reference to pancreatic diabetes.
    Włodarczyk B; Borkowska A; Włodarczyk P; Małecka-Panas E; Gąsiorowska A
    Prz Gastroenterol; 2021; 16(1):36-42. PubMed ID: 33986886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipose Triglyceride Lipase (ATGL) Expression Is Associated with Adiposity and Tumor Stromal Proliferation in Patients with Pancreatic Ductal Adenocarcinoma.
    Grace SA; Meeks MW; Chen Y; Cornwell M; Ding X; Hou P; Rutgers JK; Crawford SE; Lai JP
    Anticancer Res; 2017 Feb; 37(2):699-703. PubMed ID: 28179319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic Fibroblasts Stimulate the Motility of Pancreatic Cancer Cells through IGF1/IGF1R Signaling under Hypoxia.
    Hirakawa T; Yashiro M; Doi Y; Kinoshita H; Morisaki T; Fukuoka T; Hasegawa T; Kimura K; Amano R; Hirakawa K
    PLoS One; 2016; 11(8):e0159912. PubMed ID: 27487118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of diabetes mellitus on perioperative outcomes after resection for pancreatic adenocarcinoma.
    Chu CK; Mazo AE; Sarmiento JM; Staley CA; Adsay NV; Umpierrez GE; Kooby DA
    J Am Coll Surg; 2010 Apr; 210(4):463-73. PubMed ID: 20347739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes mellitus does not impact on clinically relevant pancreatic fistula after partial pancreatic resection for ductal adenocarcinoma.
    Malleo G; Mazzarella F; Malpaga A; Marchegiani G; Salvia R; Bassi C; Butturini G
    Surgery; 2013 May; 153(5):641-50. PubMed ID: 23276391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin/IGF-driven cancer cell-stroma crosstalk as a novel therapeutic target in pancreatic cancer.
    Mutgan AC; Besikcioglu HE; Wang S; Friess H; Ceyhan GO; Demir IE
    Mol Cancer; 2018 Feb; 17(1):66. PubMed ID: 29475434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low expression of IGFBP7 is associated with poor outcome of pancreatic ductal adenocarcinoma.
    An W; Ben QW; Chen HT; Zheng JM; Huang L; Li GX; Li ZS
    Ann Surg Oncol; 2012 Nov; 19(12):3971-8. PubMed ID: 22622471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor (IGF) axis in cancerogenesis.
    Kasprzak A; Kwasniewski W; Adamek A; Gozdzicka-Jozefiak A
    Mutat Res Rev Mutat Res; 2017; 772():78-104. PubMed ID: 28528692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.